Trial reportObstetrics and gynecology2018
Individualized Compared With Standard Postdischarge Oxycodone Prescribing After Cesarean Birth: A Randomized Controlled Trial.
Trial report in Obstetrics and gynecology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03168425 (A Randomized Controlled Trial to Improve Discharge Opioid Prescribing After Cesarean Delivery), which is not on this map. Cited by 20 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Randomized Controlled Trial to Improve Discharge Opioid Prescribing After Cesarean Delivery
Who cites it
20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 53 citations in OpenAlex.
- Pooled it
- Interventions to Reduce Inpatient and Discharge Opioid Prescribing for Postpartum Patients: A Systematic Review.Journal of midwifery & women's health · 2023Pooled it
- Leftover opioids following adult surgical procedures: a systematic review and meta-analysis.Systematic reviews · 2020Pooled it
- Enhanced discharge counseling to reduce outpatient opioid use after cesarean delivery: a randomized clinical trial.American journal of obstetrics & gynecology MFM · 2021Trial
- Preoperative Patient Education as a Tool for Reducing Postoperative Opioid Use Following Primary Total Hip Arthroplasty: One Institution's Experience.Arthroplasty today · 2025Article
- Toward Opioid-Free Total Hip Arthroplasty: A Retrospective Study of a Targeted Opioid Reduction Program in 229 Patients.Arthroplasty today · 2025Article
- Fewer Pills for Fewer Problems: Strategies for Reducing Postoperative Opioid Prescribing Following Total Joint Arthroplasty.Arthroplasty today · 2025Article
- Reducing inpatient opioid consumption after caesarean delivery: effects of an opioid stewardship programme and racial impact in a community hospital.BMJ open quality · 2024Article
- Multimodal Analgesia Bundle and Postoperative Opioid Use Among Patients Undergoing Colorectal Surgery.JAMA network open · 2023Article
- Maternal psychosocial factors associated with postpartum pain.American journal of obstetrics & gynecology MFM · 2023Observational
- Development and Validation of a Model for Opioid Prescribing Following Gynecological Surgery.JAMA network open · 2022Article
- Opioids and Public Health: The Prescription Opioid Ecosystem and Need for Improved Management.Anesthesiology · 2022Review
- Variations in Postpartum Opioid Prescribing Practices among Obstetrician-Gynecologists.Kansas journal of medicine · 2022Article
- Opioid prescription-use after cesarean delivery: an observational cohort study.Journal of anesthesia · 2021Observational
- Longitudinal patient-reported outcomes and restrictive opioid prescribing after minimally invasive gynecologic surgery.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2021Article
- Consensus Statement for the Prescription of Pain Medication at Discharge after Elective Adult Surgery.Canadian journal of pain = Revue canadienne de la douleur · 2020Article
- Factors associated with persistent pain after childbirth: a narrative review.British journal of anaesthesia · 2020Review
- Review
- Rates of New Persistent Opioid Use After Vaginal or Cesarean Birth Among US Women.JAMA network open · 2019Article
- Opioid prescribing after childbirth: overprescribing and chronic use.Current opinion in obstetrics & gynecology · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
Abstract
objectiveTo evaluate whether individualized postdischarge oxycodone prescribing guided by inpatient opioid use reduces the number of unused opioid tablets after cesarean birth.
methodsWe conducted a randomized, controlled trial of women aged 18 years or older undergoing cesarean birth. Participants were randomized at discharge in a 1:1 ratio to a standard (30 tablets of 5 mg oxycodone) or an individualized oxycodone prescription (predicted based on each patient's inpatient opioid use). All women were contacted starting 14 days after cesarean birth to assess number of oxycodone tablets used and adequacy of pain control. The Tennessee Controlled Substance Monitoring Database was accessed to confirm dispensed opioids. The primary outcome was number of unused oxycodone tablets prescribed for pain control after cesarean birth. A total sample size of 160 women was necessary to detect a 30% difference in leftover tablets between groups with 80% power and α of 0.05.
resultsBetween June 14, 2017, and August 26, 2017, we screened 323 women and randomized 172. Baseline characteristics and inpatient opioid use were similar between groups. Women in the individualized group were prescribed fewer tablets (14 [interquartile range 12-16] vs 30 [interquartile range 30-30], P<.001) and had 50% fewer unused tablets than women in the standard group (5 [interquartile range 1-8] vs 10 [interquartile range 0-22], P<.001). Overall, 13% (23/172) used no opioids after discharge and 26% (44/172) used all prescribed opioids. There were no differences between the standard and individualized groups in the proportion of women who used no opioids or all opioids and no difference in the proportion of dispensed opioids used (60% [interquartile range 23-100] vs 61% [29-89], P=.93). Women in the individualized group used only half the number of prescribed opioids as women in the standard group (8 [interquartile range 4-14] vs 15 [interquartile range 6-30], P<.001). Patient-reported pain outcomes did not differ significantly by group.
conclusionIndividualized opioid prescribing based on inpatient use reduces the number of unused oxycodone tablets compared with standard prescribing. CLINICAL TRIALS REGISTRATION: ClinicalTrials.gov, NCT03168425.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.